Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + pentazocine hydrochloride 650mg/ns caplet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin + pentazocine hydrochloride 325mg/ns tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin + pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
Has basis of strength substance (attribute) |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine hydrochloride 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
Has basis of strength substance (attribute) |
True |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine hydrochloride 25 mg oral tablet |
Has precise active ingredient |
True |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
Has precise active ingredient |
False |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
Has precise active ingredient |
True |
Pentazocine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |